Intuitive Surgical Inc.

ISRG-Q

NASDAQ:ISRG

603.36
3.01 (0.50%)
Intuitive Surgical Inc. is an American corporation that develops, manufactures and markets robotic products designed to improve clinical outcomes of patients through minimally invasive surgery, most notably with the da Vinci Surgical System.
More at Wikipedia

Analysis and Opinions about ISRG-Q

Signal
Opinion
Expert
TOP PICK
TOP PICK
January 2, 2020
The leader in robotic surgery. They sold about 900 units. He thinks they will continue to grow world-wide. (Analysts’ price target is $612.34)
Show full opinionHide full opinion
The leader in robotic surgery. They sold about 900 units. He thinks they will continue to grow world-wide. (Analysts’ price target is $612.34)
TOP PICK
TOP PICK
August 19, 2019
It is the largest company that you have never heard of. Their business is robots for surgery. It has been under a bit of pressure from a competitor but that competitor only has 4% penetration globally. (Analysts’ price target is $572.35)
Show full opinionHide full opinion
It is the largest company that you have never heard of. Their business is robots for surgery. It has been under a bit of pressure from a competitor but that competitor only has 4% penetration globally. (Analysts’ price target is $572.35)
COMMENT
COMMENT
June 12, 2019

Medical robotics? He does not know TMD-T well. He plays the space through and ETF of BOTZ-Q. He prefers ISRG-Q, if you wanted an individual holding.

Show full opinionHide full opinion

Medical robotics? He does not know TMD-T well. He plays the space through and ETF of BOTZ-Q. He prefers ISRG-Q, if you wanted an individual holding.

Kim Bolton

Unlock Ratings

Price
$501.920
Owned
Unknown
COMMENT
COMMENT
April 17, 2019
Own it through an ETF called BOTZ. That is the way he likes to play into the robotics / machine learning space.
Show full opinionHide full opinion
Own it through an ETF called BOTZ. That is the way he likes to play into the robotics / machine learning space.
TOP PICK
TOP PICK
April 18, 2018

A disruptor in medtech. ISRG builds robotic-assisted surgical devices that are sold to hospitals. Enjoys 85% recurring revenues. Growing steadily for 20 years with good intenational exposure. Their commerical shows a robot sewing the skin on a grape. Stock rose 8% today alone. Again demographics are another tailwind. (Also look at the IHI ETF in the medtech sector.) (Analysts' price target $460.80)

Show full opinionHide full opinion

A disruptor in medtech. ISRG builds robotic-assisted surgical devices that are sold to hospitals. Enjoys 85% recurring revenues. Growing steadily for 20 years with good intenational exposure. Their commerical shows a robot sewing the skin on a grape. Stock rose 8% today alone. Again demographics are another tailwind. (Also look at the IHI ETF in the medtech sector.) (Analysts' price target $460.80)

DON'T BUY
DON'T BUY
February 5, 2013

Have the robotic methodology for surgical procedures, which has been very successful but it is priced in. Great company. Trading at 35X earnings which is too expensive.

Show full opinionHide full opinion

Have the robotic methodology for surgical procedures, which has been very successful but it is priced in. Great company. Trading at 35X earnings which is too expensive.

DON'T BUY
DON'T BUY
January 11, 2012
Surgical tool for surgeons to use like a robot. He is worried about it getting well ahead of itself. If anything goes wrong there is a lot of air under that stock price.
Show full opinionHide full opinion
Surgical tool for surgeons to use like a robot. He is worried about it getting well ahead of itself. If anything goes wrong there is a lot of air under that stock price.
Gordon Reid

Unlock Ratings

Price
$456.950
Owned
Unknown
DON'T BUY
DON'T BUY
January 13, 2010
A high-growth story but too expensive for him now. High beta of 1.3.
Show full opinionHide full opinion
A high-growth story but too expensive for him now. High beta of 1.3.
Showing 1 to 8 of 8 entries
  • «
  • 1
  • »